Search for Clinical Trial Results
Optic Pathway Glioma - 25 Studies Found
Status | Study |
Terminated |
Study Name: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Condition:
|
Recruiting |
Study Name: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Condition:
|
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition:
|
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition:
|
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condition:
|
Recruiting |
Study Name: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Condition:
|
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition:
|
Completed |
Study Name: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Condition:
|
Completed |
Study Name: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Condition:
|
Completed |
Study Name: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas Condition:
Interventions: |